[Homograft in the therapy of cardiovascular diseases].
Despite considerable progress in prosthetic valve technology, there is actually no ideal artificial heart valve that may be employed in all circumstances, when replacement of a diseased aortic valve is necessary. The choice for optimal valve substitute includes mechanical prosthesis, bioprosthetic xenografts, homografts and pulmonary autografts. More recently an aortic valve sparing operation has been proposed in younger patients presenting with anulo-aortic ectasia. The use of homograft heart valves has now been widely accepted in the treatment of congenital heart defects, as well as for an increasing number of valvular pathologies, especially in infective endocarditis. Heart valve preservation by cryopreservation techniques helps to store the small amount of donor material for special indications without loss of quality, thus permitting elective surgery. In vascular surgery, some concern persists regarding the use of prosthetic material for the treatment of mycotic aneurysms and graft infection. In situ repair with a new vascular prosthesis and resection followed by extra-anatomic reconstruction carry a high peri-operative mortality and substantial morbidity. Cryopreserved vascular homografts represent a valuable alternative in these challenging situations.
Striffeler
H
H
Klinik für Thorax-, Herz- und Gefässchirurgie, Universitätsspital Bern.
Kipfer
B
B
Althaus
U
U
Carrel
T
T
D001021:Aortic Valve / Q000637:transplantation; D001808:Blood Vessels / Q000637:transplantation*; D002318:Cardiovascular Diseases / Q000601:surgery*; D005615:Freezing; D006351:Heart Valves / Q000637:transplantation*; D006801:Humans; D011309:Preservation, Biological; D011651:Pulmonary Artery / Q000637:transplantation; D014184:Transplantation, Homologous / Q000379:methods
Der Homograft in der Therapie von kardiovaskulären Erkrankungen.